Latest news and insights on the pharmaceutical industry | Indian Pharma Post | Page 231

Results For "CRO"

4634 News Found

EnginZyme produces key mRNA vaccine ingredient using biocatalysis
Biotech | October 30, 2023

EnginZyme produces key mRNA vaccine ingredient using biocatalysis

2023 Nobel laureates discovered how pseudouridine could make mRNA suitable for vaccines


Tanaka develops first high entropy precious metals alloy powder
News | October 30, 2023

Tanaka develops first high entropy precious metals alloy powder

With the establishment of five different precious metals alloy powder production methods


Pfizer and BioNTech announce data for mRNA-based vaccine program for influenza and COVID-19
News | October 30, 2023

Pfizer and BioNTech announce data for mRNA-based vaccine program for influenza and COVID-19

The companies plan to start a pivotal Phase 3 trial in the coming months


Sumitomo Pharma announces authorization in Canada of Orgovyx for treatment prostate cancer
News | October 25, 2023

Sumitomo Pharma announces authorization in Canada of Orgovyx for treatment prostate cancer

Orgovyx is the first and only oral GnRH receptor antagonist approved for advanced prostate cancer in Canada


RPG Life Sciences posts Q2 FY24 PAT at Rs. 25.86 Cr
News | October 23, 2023

RPG Life Sciences posts Q2 FY24 PAT at Rs. 25.86 Cr

RPG Life Sciences has reported total income of Rs. 155.41 crores during the period ended September 30, 2023


Indoco Remedies posts consolidated Q2FY24 PAT at Rs. 35.08 Cr
News | October 23, 2023

Indoco Remedies posts consolidated Q2FY24 PAT at Rs. 35.08 Cr

The company has reported total income of Rs. 486.16 crores during the period ended September 30, 2023


India should take global leadership with Holistic Healthcare Approach: Sonowal
Policy | October 23, 2023

India should take global leadership with Holistic Healthcare Approach: Sonowal

New Molecular biology lab launched, AIIA increased its work scope in form of MoUs


Aarti Drugs Q2 FY24 consolidated net profit drops QOQ to Rs. 39.59 Cr
News | October 21, 2023

Aarti Drugs Q2 FY24 consolidated net profit drops QOQ to Rs. 39.59 Cr

Aarti Drugs has reported total income of Rs. 642.22 crores during the period ended September 30, 2023


Laurus Labs Q2 FY24 consolidated PAT up QOQ at Rs. 36.95 Cr
News | October 21, 2023

Laurus Labs Q2 FY24 consolidated PAT up QOQ at Rs. 36.95 Cr

Laurus Labs has reported total income of Rs. 1226.23 crores during the period ended September 30, 2023


Evonik strengthens nanoparticle technologies and services portfolio for parenteral drug delivery
News | October 21, 2023

Evonik strengthens nanoparticle technologies and services portfolio for parenteral drug delivery

Three block copolymers added to RESOMER portfolio of bioabsorbable polymers